Explore geospatial data from UT Austin and beyond

View Metadata

United States Cancer Mortality 1970-1994

Identification Information
Citation
Originator
U.S. Geological Survey
Publication Date
200008
Title
United States Cancer Mortality 1970-1994
Publication Information
Publication Place
Reston, VA
Publisher
U.S. Geological Survey
Online Linkage
http://www.columbia.edu/acis/eds/gis/images/natatlas_1994_us_cancer.zip
Abstract
This data set contains 1970-1994 cancer mortality information for counties in the United States. Included are death rates, number of deaths, confidence levels, and expected number of deaths for white males and white females for 20 cancers. The data are from a cancer mapping project in the National Cancer Institute's (NCI) Division of Cancer Epidemiology and Genetics (DCEG).
Purpose
These data are intended for geographic display and analysis at the national level, and for large regional areas. The data should be displayed and analyzed at scales appropriate for 1:2,000,000-scale data. No responsibility is assumed by the U.S. Geological Survey in the use of these data.
Temporal Extent
Currentness Reference
ground condition
Time Period
Beginning
1974
End
1994
Bounding Box
West
172
East
-66
North
72
South
18
Theme Keyword
Death
Death rates
Mortality
Human mortality
Cancer
All cancers
Bladder cancer
Brain and other nervous system cancer
Breast cancer
Cervix uteri cancer
Colon cancer
Esophagus cancer
Kidney, renal pelvis, and ureter cancer
leukemia
Liver, gallbladder, and other biliary tract cancer
Lung, trachea, bronchus, and pleura cancer
Non-Hodgkin's lymphoma cancer
Oral cavity and pharynx cancer
Other and unspecified cancers cancer
Ovary cancer
Pancreas cancer
Prostate cancer
Rectum cancer
Stomach cancer
Corpus uteri and uterus not otherwise specified cancer
Theme Keyword Thesaurus
None
Theme Keyword
health
society
Theme Keyword Thesaurus
ISO 19115 Topic Categories
Place Keyword
United States
USA
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Place Keyword Thesaurus
U.S. Department of Commerce, 1987, Codes for the Identification of the States, the District of Columbia and the Outlying Areas of The United States, and Associated Areas (Federal Information Processing Standard 5-2): Washington, DC, National Institute of Standards and Technology.
Access Restrictions
None
Use Restrictions
None
Status
Complete
Maintenance and Update Frequency
None planned
Point of Contact
Contact Organization
U.S. Geological Survey
Delivery Point
521 National Center
City
Reston
State
VA
Postal Code
20192
Data Quality Information
Logical Consistency Report
The data set was checked for topological consistency using the Arc/INFO command BUILD. No other checks for logical consistency were performed on this data set.
Completeness Report
This data set includes cancer mortality data for all 50 States.
Lineage
Source
Originator
U.S. Geological Survey
Publication Date
200003
Title
County Boundaries of the United States
Publication Information
Publication Place
Reston, VA
Publisher
U.S. Geological Survey
Type of Source Media
Internal database
Source Temporal Extent
Time Period Information
Range of Dates/Times
Beginning Date
1972
Ending Date
1980
Source Currentness Reference
ground condition
Source
Originator
National Cancer Institute
Publication Date
199909
Title
Atlas of Cancer Mortality in the United States, 1950-94
Publication Information
Publication Place
Bethesda, MD
Publisher
Department of Health and Human Services, National Institutes of Health, National Cancer Institute
Type of Source Media
online
Source Temporal Extent
Time Period Information
Range of Dates/Times
Beginning Date
1970
Ending Date
1994
Source Currentness Reference
ground condition
Source
Originator
National Cancer Institute
Publication Date
199909
Title
Atlas of Cancer Mortality in the United States, 1950-94
Publication Information
Publication Place
Bethesda, MD
Publisher
Department of Health and Human Services, National Institutes of Health, National Cancer Institute
Type of Source Media
electronic mail system
Source Temporal Extent
Time Period Information
Range of Dates/Times
Beginning Date
1970
Ending Date
1994
Source Currentness Reference
ground condition
Spatial Data Organization Information
Indirect Spatial Reference Method
U.S. Department of Commerce, 1995, Countries, Dependencies, Areas of Special Sovereignty, and Their Principal Administrative Divisions. (Federal Information Processing Standard (FIPS) 10-4): Washington, DC, National Institute of Standards and Technology. U.S. Department of Commerce, 1987, Codes for the Identification of the States, the District of Columbia and the Outlying Areas of The United States, and Associated Areas (Federal Information Processing Standard (FIPS) 5-2): Washington, DC, National Institute of Standards and Technology. U.S. Department of Commerce, 1990, Counties and Equivalent Entities of The United States, Its Possessions, and Associated Areas (Federal Information Processing Standard 6-4): Washington, DC, National Institute of Standardsand Technology.
Direct Spatial Reference Method
Vector
Point and Vector Object Information
SDTS Terms Description
SDTS Point and Vector Object Type
GT-polygon composed of chains
Point and Vector Object Count
5905
Spatial Reference Information
Horizontal Coordinate System Definition
Geographic
Latitude Resolution
0.000278
Longitude Resolution
0.000278
Geographic Coordinate Units
Decimal degrees
Geodetic Model
Horizontal Datum Name
North American Datum of 1983
Ellipsoid Name
GRS1980
Semi-major Axis
6378137
Denominator of Flattening Ratio
298.257222
Entity and Attribute Information
Entity Type
Entity Type Label
Cancer mortality data (described by Cancerp020.dbf)
Entity Type Definition
Information on deaths due to various types of cancer.
Entity Type Definition Source
U.S. Geological Survey
Attributes
FID
Internal feature number. (Sequential unique whole numbers that are automatically generated.)
Shape
Feature geometry. (Coordinates defining the features.)
AREA
The area of the polygon in coverage units.
PERIMETER
The perimeter of the area in coverage units.
CANCERP020
Internal feature number
STATE
The 2-character FIPS code of the State or State equivalent. (Codes for the Identification of the States, the District of Columbia and the Outlying Areas of the United States, and Associated Areas, FIPS 5-2. U.S. Department of Commerce, National Institute of Standards and Technology)
NCI_UNIT
The name of the reporting unit used by the National Cancer Institute. For most of the data these are counties. Alaska and Hawaii are each single reporting unit. In Montana, New York, and Wisconsin some counties were combined to create the NCI reporting unit. In Virginia independent cities were combined with the surrounding counties to create the NCI reporting unit. (Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas, FIPS 6-4, 1990.U.S. Department of Commerce, National Institute of Standards and Technology )
STATE_FIPS
The 2-digit FIPS code of the State or State equivalent. (Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas, FIPS 6-4, 1990.U.S. Department of Commerce, National Institute of Standards and Technology )
NCI_FIPS
The 5-digit county FIPS code of the reporting unit used by the National Cancer Institute. For most of the data the reporting units are counties. In Montana, New York, and Wisconsin some counties were combined to create the NCI reporting unit. In Virginia independent cities were combined with the surrounding counties to create the NCI reporting unit. Data for Alaska and Hawaii were available at the State level only. Alaska and Hawaii were coded as 02999 and 15999, respectively, and were considered as counties in the maps.
ACCF_RATE
This is the death rate due to All cancers per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
ACCF_CNT
This is the number of deaths due to All cancers for females. (0 to 151853)
ACCF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to All cancers for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
ACCF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to All cancers for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
ACCF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where All cancers is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
ACCF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where All cancers is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
ACCF_ECNT
This is the expected number of deaths due to All cancers for females based on U.S. mortality rates. (0 to 152166)
ACCM_RATE
This is the death rate due to all cancers per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
ACCM_CNT
This is the number of deaths due to all cancers for males. (0 to 151853)
ACCM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to all cancers for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
ACCM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to all cancers for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
ACCM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where All cancers is the cancer and male is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
ACCM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where All cancers is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
ACCM_ECNT
This is the expected number of deaths due to all cancers for males based on U.S. mortality rates. (0 to 152166)
BLAF_RATE
This is the death rate due to bladder cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
BLAF_CNT
This is the number of deaths due to bladder cancer for females. (0 to 151853)
BLAF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to bladder cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
BLAF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to bladder cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
BLAF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where bladder cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
BLAF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where bladder cancer is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
BLAF_ECNT
This is the expected number of deaths due to bladder cancer for females based on U.S. mortality rates. (0 to 152166)
BLAM_RATE
This is the death rate due to bladder cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
BLAM_CNT
This is the number of deaths due to bladder cancer for males. (0 to 151853)
BLAM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to bladder cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
BLAM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to bladder cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
BLAM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where bladder cancer is the cancer and male is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
BLAM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where bladder cancer is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
BLAM_ECNT
This is the expected number of deaths due to bladder cancer for males based on U.S. mortality rates. (0 to 152166)
BRAF_RATE
This is the death rate due to brain and other nervous system cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
BRAF_CNT
This is the number of deaths due to brain and other nervous system cancer for females. (0 to 151853)
BRAF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to brain and other nervous system cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
BRAF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to brain and other nervous system cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
BRAF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where brain and other nervous system cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
BRAF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where brain and other nervous system cancer is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
BRAF_ECNT
This is the expected number of deaths due to brain and other nervous system cancer for females based on U.S. mortality rates. (0 to 152166)
BRAM_RATE
This is the death rate due to brain and other nervous system cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
BRAM_CNT
This is the number of deaths due to brain and other nervous system cancer for males. (0 to 151853)
BRAM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to brain and other nervous system cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
BRAM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to brain and other nervous system cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
BRAM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where brain and other nervous system cancer is the cancer and male is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
BRAM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where brain and other nervous system cancer is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
BRAM_ECNT
This is the expected number of deaths due to brain and other nervous system cancer for males based on U.S. mortality rates. (0 to 152166)
BREF_RATE
This is the death rate due to breast cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
BREF_CNT
This is the number of deaths due to breast cancer for females. (0 to 151853)
BREF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to breast cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
BREF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to breast cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
BREF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where breast cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
BREF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where breast cancer is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
BREF_ECNT
This is the expected number of deaths due to breast cancer for females based on U.S. mortality rates. (0 to 152166)
CERF_RATE
This is the death rate due to cervix uteri cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
CERF_CNT
This is the number of deaths due to cervix uteri cancer for females. (0 to 151853)
CERF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to cervix uteri cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
CERF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to cervix uteri cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
CERF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where cervix uteri cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
CERF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where cervix uteri cancer is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
CERF_ECNT
This is the expected number of deaths due to cervix uteri cancer for females based on U.S. mortality rates. (0 to 152166)
COLF_RATE
This is the death rate due to colon cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
COLF_CNT
This is the number of deaths due to colon cancer for females. (0 to 151853)
COLF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to colon cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
COLF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to colon cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
COLF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where colon cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
COLF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where colon cancer is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
COLF_ECNT
This is the expected number of deaths due to colon cancer for females based on U.S. mortality rates. (0 to 152166)
COLM_RATE
This is the death rate due to colon cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
COLM_CNT
This is the number of deaths due to colon cancer for males. (0 to 151853)
COLM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to colon cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
COLM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to colon cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
COLM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where colon cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
COLM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where colon cancer is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
COLM_ECNT
This is the expected number of deaths due to colon cancer for males based on U.S. mortality rates. (0 to 152166)
ESOF_RATE
This is the death rate due to esophagus cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
ESOF_CNT
This is the number of deaths due to esophagus cancer for females. (0 to 151853)
ESOF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to esophagus cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
ESOF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to esophagus cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
ESOF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where esophagus cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
ESOF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where esophagus cancer is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
ESOF_ECNT
This is the expected number of deaths due to esophagus cancer for females based on U.S. mortality rates. (0 to 152166)
ESOM_RATE
This is the death rate due to esophagus cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
ESOM_CNT
This is the number of deaths due to esophagus cancer for males. (0 to 151853)
ESOM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to esophagus cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
ESOM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to esophagus cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
ESOM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where esophagus cance is the cancer and male is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
ESOM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where esophagus cance is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
ESOM_ECNT
This is the expected number of deaths due to esophagus cancer for males based on U.S. mortality rates. (0 to 152166)
KIDF_RATE
This is the death rate due to kidney, renal pelvis, and ureter cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
KIDF_CNT
This is the number of deaths due to kidney, renal pelvis, and ureter cancer for females. (0 to 151853)
KIDF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to kidney, renal pelvis, and ureter cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
KIDF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to kidney, renal pelvis, and ureter cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
KIDF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where kidney, renal pelvis, and ureter cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
KIDF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where kidney, renal pelvis, and ureter cancer is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
KIDF_ECNT
This is the expected number of deaths due to kidney, renal pelvis, and ureter cancer for females based on U.S. mortality rates. (0 to 152166)
KIDM_RATE
This is the death rate due to kidney, renal pelvis, and ureter cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
KIDM_CNT
This is the number of deaths due to kidney, renal pelvis, and ureter cancer for males. (0 to 151853)
KIDM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to kidney, renal pelvis, and ureter cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
KIDM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to kidney, renal pelvis, and ureter cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
KIDM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where kidney, renal pelvis, and ureter cancer is the cancer and male is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
KIDM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where kidney, renal pelvis, and ureter cancer is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
KIDM_ECNT
This is the expected number of deaths due to kidney, renal pelvis, and ureter cancer for males based on U.S. mortality rates. (0 to 152166)
LEUF_RATE
This is the death rate due to leukemia per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
LEUF_CNT
This is the number of deaths due to leukemia for females. (0 to 151853)
LEUF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to leukemia for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
LEUF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to leukemia for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
LEUF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where leukemia is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
LEUF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where leukemia is the cancer and feamle is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
LEUF_ECNT
This is the expected number of deaths due to leukemia for females based on U.S. mortality rates. (0 to 152166)
LEUM_RATE
This is the death rate due to leukemia per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
LEUM_CNT
This is the number of deaths due to leukemia for males. (0 to 151853)
LEUM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to leukemia for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
LEUM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to leukemia for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
LEUM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where leukemia is the cancer and male is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
LEUM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where leukemia is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
LEUM_ECNT
This is the expected number of deaths due to leukemia for males based on U.S. mortality rates. (0 to 152166)
LGBF_RATE
This is the death rate due to liver, gallbladder, and other biliary tract cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
LGBF_CNT
This is the number of deaths due to liver, gallbladder, and other biliary tract cancer for females. (0 to 151853)
LGBF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to liver, gallbladder, and other biliary tract cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
LGBF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to liver, gallbladder, and other biliary tract cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
LGBF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where liver, gallbladder, and other biliary tract cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
LGBF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where liver, gallbladder, and other biliary tract cancer is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
LGBF_ECNT
This is the expected number of deaths due to liver, gallbladder, and other biliary tract cancer for females based on U.S. mortality rates. (0 to 152166)
LGBM_RATE
This is the death rate due to liver, gallbladder, and other biliary tract cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
LGBM_CNT
This is the number of deaths due to liver, gallbladder, and other biliary tract cancer for males. (0 to 151853)
LGBM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to liver, gallbladder, and other biliary tract cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
LGBM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to liver, gallbladder, and other biliary tract cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
LGBM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where liver, gallbladder, and other biliary tract cancer is the cancer and male is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
LGBM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where liver, gallbladder, and other biliary tract cancer is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
LGBM_ECNT
This is the expected number of deaths due to liver, gallbladder, and other biliary tract cancer for males based on U.S. mortality rates. (0 to 152166)
LUNF_RATE
This is the death rate due to lung, trachea, bronchus, and pleura cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
LUNF_CNT
This is the number of deaths due to lung, trachea, bronchus, and pleura cancer for females. (0 to 151853)
LUNF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to lung, trachea, bronchus, and pleura cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
LUNF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to lung, trachea, bronchus, and pleura cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
LUNF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where lung, trachea, bronchus, and pleura cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
LUNF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where lung, trachea, bronchus, and pleura cancer is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
LUNF_ECNT
This is the expected number of deaths due to lung, trachea, bronchus, and pleura cancer for females based on U.S. mortality rates. (0 to 152166)
LUNM_RATE
This is the death rate due to lung, trachea, bronchus, and pleura cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
LUNM_CNT
This is the number of deaths due to lung, trachea, bronchus, and pleura cancer for males. (0 to 151853)
LUNM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to lung, trachea, bronchus, and pleura cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
LUNM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to lung, trachea, bronchus, and pleura cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
LUNM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where lung, trachea, bronchus, and pleura cancer is the cancer and male is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
LUNM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where lung, trachea, bronchus, and pleura cancer is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
LUNM_ECNT
This is the expected number of deaths due to lung, trachea, bronchus, and pleura cancer for males based on U.S. mortality rates. (0 to 152166)
NHLF_RATE
This is the death rate due to non-Hodgkin's lymphoma per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
NHLF_CNT
This is the number of deaths due to non-Hodgkin's lymphoma for females. (0 to 151853)
NHLF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to non-Hodgkin's lymphoma for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
NHLF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to non-Hodgkin's lymphoma for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
NHLF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where non-Hodgkin's lymphoma is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
NHLF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where non-Hodgkin's lymphoma is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
NHLF_ECNT
This is the expected number of deaths due to non-Hodgkin's lymphoma for females based on U.S. mortality rates. (0 to 152166)
NHLM_RATE
This is the death rate due to non-Hodgkin's lymphoma per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
NHLM_CNT
This is the number of deaths due to non-Hodgkin's lymphoma for males. (0 to 151853)
NHLM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to non-Hodgkin's lymphoma for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
NHLM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to non-Hodgkin's lymphoma for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
NHLM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where non-Hodgkin's lymphoma is the cancer and male is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
NHLM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where non-Hodgkin's lymphoma is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
NHLM_ECNT
This is the expected number of deaths due to non-Hodgkin's lymphoma for males based on U.S. mortality rates. (0 to 152166)
ORAF_RATE
This is the death rate due to oral cavity and pharynx cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
ORAF_CNT
This is the number of deaths due to oral cavity and pharynx cancer for females. (0 to 151853)
ORAF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to oral cavity and pharynx cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
ORAF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to oral cavity and pharynx cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
ORAF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where oral cavity and pharynx cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
ORAF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where oral cavity and pharynx cancer is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
ORAF_ECNT
This is the expected number of deaths due to oral cavity and pharynx cancer for females based on U.S. mortality rates. (0 to 152166)
ORAM_RATE
This is the death rate due to oral cavity and pharynx cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
ORAM_CNT
This is the number of deaths due to oral cavity and pharynx cancer for males. (0 to 151853)
ORAM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to oral cavity and pharynx cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
ORAM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to oral cavity and pharynx cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
ORAM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where oral cavity and pharynx cancer is the cancer and male is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
ORAM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where oral cavity and pharynx cancer is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
ORAM_ECNT
This is the expected number of deaths due to oral cavity and pharynx cancer for males based on U.S. mortality rates. (0 to 152166)
OTHF_RATE
This is the death rate due to other and unspecified cancers per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
OTHF_CNT
This is the number of deaths due to other and unspecified cancers for females. (0 to 151853)
OTHF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to other and unspecified cancers for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
OTHF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to other and unspecified cancers for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
OTHF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where other and unspecified cancers is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
OTHF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where other and unspecified cancers is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
OTHF_ECNT
This is the expected number of deaths due to other and unspecified cancers for females based on U.S. mortality rates. (0 to 152166)
OTHM_RATE
This is the death rate due to other and unspecified cancers per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
OTHM_CNT
This is the number of deaths due to other and unspecified cancers for males. (0 to 151853)
OTHM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to other and unspecified cancers for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
OTHM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to other and unspecified cancers for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
OTHM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where other and unspecified cancers is the cancer and male is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
OTHM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where other and unspecified cancers is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
OTHM_ECNT
This is the expected number of deaths due to other and unspecified cancers for males based on U.S. mortality rates. (0 to 152166)
OVAF_RATE
This is the death rate due to ovary cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
OVAF_CNT
This is the number of deaths due to ovary cancer for females. (0 to 151853)
OVAF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to ovary cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
OVAF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to ovary cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
OVAF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where ovary cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
OVAF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where ovary cancer is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
OVAF_ECNT
This is the expected number of deaths due to ovary cancer for females based on U.S. mortality rates. (0 to 152166)
PANF_RATE
This is the death rate due to pancreas cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
PANF_CNT
This is the number of deaths due to pancreas cancer for females. (0 to 151853)
PANF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to pancreas cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
PANF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to pancreas cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
PANF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where pancreas cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
PANF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where pancreas cancer is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
PANF_ECNT
This is the expected number of deaths due to pancreas cancer for females based on U.S. mortality rates. (0 to 152166)
PANM_RATE
This is the death rate due to pancreas cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
PANM_CNT
This is the number of deaths due to pancreas cancer for males. (0 to 151853)
PANM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to pancreas cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
PANM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to pancreas cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
PANM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where pancreas cancer is the cancer and male is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
PANM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where pancreas cancer is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
PANM_ECNT
This is the expected number of deaths due to pancreas cancer for males based on U.S. mortality rates. (0 to 152166)
PROM_RATE
This is the death rate due to prostate cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
PROM_CNT
This is the number of deaths due to prostate cancer for males. (0 to 151853)
PROM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to prostate cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
PROM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to prostate cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
PROM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where prostate cancer is the cancer and male is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
PROM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where prostate cancer is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
PROM_ECNT
This is the expected number of deaths due to prostate cancer for males based on U.S. mortality rates. (0 to 152166)
RECF_RATE
This is the death rate due to rectum cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
RECF_CNT
This is the number of deaths due to rectum cancer for females. (0 to 151853)
RECF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to rectum cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
RECF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to rectum cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
RECF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where rectum cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
RECF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where rectum cancer is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
RECF_ECNT
This is the expected number of deaths due to rectum cancer for females based on U.S. mortality rates. (0 to 152166)
RECM_RATE
This is the death rate due to rectum cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
RECM_CNT
This is the number of deaths due to rectum cancer for males. (0 to 151853)
RECM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to rectum cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
RECM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to rectum cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
RECM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where rectum cancer is the cancer and male is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
RECM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where rectum cancer is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
RECM_ECNT
This is the expected number of deaths due to rectum cancer for males based on U.S. mortality rates. (0 to 152166)
STOF_RATE
This is the death rate due to stomach cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
STOF_CNT
This is the number of deaths due to stomach cancer for females. (0 to 151853)
STOF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to stomach cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
STOF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to stomach cancer for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
STOF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where stomach cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
STOF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where stomach cancer is the cancer and femal is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
STOF_ECNT
This is the expected number of deaths due to stomach cancer for females based on U.S. mortality rates. (0 to 152166)
STOM_RATE
This is the death rate due to stomach cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
STOM_CNT
This is the number of deaths due to stomach cancer for males. (0 to 151853)
STOM_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to stomach cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
STOM_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to stomach cancer for males. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
STOM_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where stomach cancer is the cancer and male is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
STOM_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where stomach cancer is the cancer and male is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
STOM_ECNT
This is the expected number of deaths due to stomach cancer for males based on U.S. mortality rates. (0 to 152166)
UTEF_RATE
This is the death rate due to corpus uteri and uterus not otherwise specified cancerX per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. (0 to 892.9)
UTEF_CNT
This is the number of deaths due to corpus uteri and uterus not otherwise specified cancerX for females. (0 to 151853)
UTEF_LB
This is the lower bound of the 95% confidence interval on the mortality rate due to corpus uteri and uterus not otherwise specified cancerX for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (0 to 786.1)
UTEF_UB
This is the upper bound of the 95% confidence interval on the mortality rate due to corpus uteri and uterus not otherwise specified cancerX for females. The 95% confidence interval determines whether the mortality rate for a particular county is significantly different from the total U.S. rate. (87.72 to 999.71)
UTEF_LBUUS
This is the lower bound of the 95% confidence interval on cancer mortality minus the upper bound of the 95% confidence interval on the U.S. mortality rate where corpus uteri and uterus not otherwise specified cancer is the cancer and female is the gender. This value is used to determine whether the rate for a specific county is based on sparse data, as defined in th National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94 (-209.66 to 576.44)
UTEF_LUSUB
This is the lower bound of the 95% confidence interval on U.S. mortality rate minus the upper bound of the 95% confidence interval on the cancer mortality rate where corpus uteri and uterus not otherwise specified cancer is the cancer and female is the gender. This value is used to determine whether the mortality rate for a specific county is based on sparse data, as defined in the National Cancer Institute's Atlas of Cancer Mortality in the United States, 1950-94. (-790.42 to 80.89)
UTEF_ECNT
This is the expected number of deaths due to corpus uteri and uterus not otherwise specified cancerX for females based on U.S. mortality rates. (0 to 152166)
ACCM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for all cancers per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
ACCF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for all cancers per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
BLAM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Bladder cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
BLAF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Bladder cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
BRAM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for brain and other nervous system cancers per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
BRAF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for brain and other nervous system cancers per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
BREF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Breast cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
CERF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for cervix uteri cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
COLM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for colon cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
COLF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for colon cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
ESOM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for esophagus cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
ESOF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for esophagus cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
KIDM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for kidney, renal pelvis, and ureter cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
KIDF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for kidney, renal pelvis, and ureter cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
LEUM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Leukemia per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
LEUF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Leukemia per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
LGBM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Liver, gallbladder, and other biliary tract cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
LGBF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Liver, gallbladder, and other biliary tract cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
LUNM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Lung, trachea, bronchus, and pleura cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
LUNF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Lung, trachea, bronchus, and pleura cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
NHLM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Non-Hodgkin's lymphoma per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
NHLF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Non-Hodgkin's lymphoma per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
ORAM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Oral cavity and pharynx cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
ORAF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Oral cavity and pharynx cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
OTHM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Other and unspecified cancers per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
OTHF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Other and unspecified cancers per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
OVAF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Ovary cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
PANM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Pancreas cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
PANF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Pancreas cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
PROM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Prostate cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
RECM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Rectum cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
RECF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Rectum cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
STOM_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for Stomach cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
STOF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for stomach cancer per 100,000 population for males. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
UTEF_SP
This field was used to create the maps in the National Atlas of the United States and the Atlas of Cancer Mortality in the United States: 1950-94. It is the death rate excluding areas considered unstable by the National Cancer Institute. The rates are for ccorpus uteri and uterus not otherwise specified cancer per 100,000 population for females. The numbers are age-adjusted to the 1970 U.S. population. An area was considered unstable if (a) the observed number of deaths was less than 6; (b) the observed number of deaths was less than 12 and the rate was not significantly different statistically from the U.S. rate; or (c) the expected number of deaths was less than 6 and the rate was not significantly different statistically from the U.S. rate.
Distribution Information
Format Name
ESRI Shapefile
Distributor
Research Data Services (RDS) Data Service, Columbia University Libraries
Name
Metadata Reference Information
Metadata Date
20140825
Metadata Contact
Contact Information
Contact Person Primary
Contact Person
Contact Organization
Research Data Services (RDS)
Contact Address
Address
420 W. 118th St., 215 IAB, MC 3301
Address
MS-561
City
New York
State or Province
NY
Postal Code
11217
Contact Voice Telephone
(212)854-601
Contact Electronic Mail Address
data@library.columbia.edu
Metadata Standard Name
FGDC Content Standards for Digital Geospatial Metadata
Metadata Standard Version
FGDC-STD-001-1998
Download